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Abstract 
Objective: To find the frequency of ovarian lesions in various 
ages at Pathology Department, ANMC Islamabad 
Material and Methods: This Cross sectional study was 
conducted in department of Pathology ANMC Islamabad from 
1stJanuary 2015 to 30th June 2016. About 178 cases of ovarian 
lesions were included in the study. The samples were processed as 
per recommended steps for histopathological diagnosis. Data was 
recorded and analyzed by using SPSS version 20. Frequencies for 
specific diseases were calculated in terms of percentages. Mean 
and standard deviation were calculated for numerical values. 
Results: Among 178 ovarian specimens, commonest pathology 
was non-neoplastic cysts in 78 cases (43.8 %) followed by benign 
tumors in 74 cases(41.6 %) and malignant tumors in 26 cases 
(14.6 %). The common lesions were endometriotic cysts 21.3 %, 
serous cystadenoma 17.4 %, benign cystic teratoma 14 %, 
follicular cyst 12.3 %, hemorrhagic cysts 10.1% and mucinous 
cystadenoma 7.3 %. Common malignant tumors were serous 
cystadenocarcinoma 6.7%, mucinous cystadenocarcinoma 2.8% 
and endometroid carcinoma 1.7% . 
Conclusion: Non neoplastic cysts were the most common 
ovarian lesions (43.8%). This was followed by benign (41/6%) 
and malignant tumors (14.6%) cases. Surface epithelial tumors 
were more common than other tumors. 
Key Words:  Frequency, Malignant ovarian tumors, Serous 
cystadenoma, Teratomas. 
 
Introduction 
Ovaries are paired bean-shaped female reproductive organs. 
The germ cells along with the multipotential and 
totipotential mesenchymal cells are mainly performing the 
ovarian functions. In case of any ovarian pathology, 
definitely the reproductive functions will be disturbed.
 
Some of the non- neoplastic lesions of the ovary form large 
masses and mimic malignant neoplasms and therefore they 
should be properly recognized and classified to allow 
appropriate therapy.
1
 Prompt diagnosis, categorization, 
stage of disease, and hence management of any benign or 
malignant ovarian pathology is a challenging task for 
gynecologists.
2
 Ovarian cancer is the seventh leading cause 
of cancer death in females and in postmenopausal women 
30% of ovarian tumors are malignant whereas in 
premenopausal females only 7% of the ovarian tumors are 
malignant.
1
 Berek et al in 2007 described that the benign 
ovarian pathology is most commonly seen in younger aged 
females of around 20 years. However, the malignant ones 
are either seen between the ages of 50-60 years or in pre-
menopausal ages. It was also highlighted that the prognostic 
outcomes are good in ages less than 40 yrs.
3 
Delay in 
diagnosis leads to the disease progression along with the 
emergence of complications. Thus, the management options 
in that situation used to be limited, resulting in increased 
mortality rate.
4
 The current study was planned to identify 
the spectrum of ovarian pathologies in our setup. Awareness 
regarding their presentation in various age groups, can be 
helpful for the gynecologists to diagnose early and hence 
manage them prior the development of complications. 
Material and Methods 
The current study was conducted at pathology department 
of Al Nafees Medical College & Hospital, Islamabad, 
Pakistan from January 01
st
, 2015 to June 30
th
, 2016. All 
specimens received during the study period for diagnosis of 
ovarian diseases were included in the study. A total of 178 
specimens were analyzed. All specimens were collected in 
10% buffered formal saline and processed in automated 
tissue processor. Paraffin embedded sections were made 
and stained with the hematoxylin and eosin stains. Data was 
entered on SPSS version 20.0 for statistical inference. 
Results 
Among various ovarian lesions, non-neoplastic and 
functional cysts were the most common lesion found in 
43.8% (n=78) of patients. These comprised endometriotic 
cysts 21.3% (n=38), follicular cyst 12.3% (n=22) and 
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hemorrhagic cysts including luteal cysts 10.2% (n=18). 
Among the ovarian tumors, the benign tumors were about 
three times common as compared to malignant ones as 
benign lesions were seen in 74 (85.4%) cases while 26 
(14.6%) of the cases were malignant. The detail of these 
lesions is given in table 1. 
Malignant ovarian tumors were all primary tumors except 
one case of metastatic signet cell carcinoma (Krukenberg 
tumor). Among the primary malignant tumors, epithelial 
tumors were the most common accounting for 84 %(n=21), 
followed by germ cell tumors 12% (n=3) and one case of 
undifferentiated sarcoma (4 %). On the basis of 
histogenesis, surface epithelial tumors comprised two third 
of cases-66% followed by germ cell tumors 28 %. Among 
epithelial tumors, mostly were benign (45%) while 21% 
were malignant. Serous tumors both benign and malignant 
were the commonest tumour in this study as shown in table 
2.  
Table 1: Frequency of Various Ovarian Lesions with Mean 
Ages (n=178) 
Sr.
No 
Types of Lesions No. of 
cases (n) 
Percen
tages 
(%) 
Age (years) 
mean±SD 
A. Non-Neoplastic/functional cysts - 
78(43.8 %) 
 
30+ 1.6 
 
 
 
 
 
37 + 1.8 
1.  Endometriotic Cyst 38 21.2   
2.  Follicular Cyst 22 12.3 
3.  Hemorrhagic/  luteal 
cyst 
18 10.3 
B. Primary Tumors 
i. Benign- 74 (41.6%) 
1.  Serous cystadenoma 31 17.4  
2.  Benign cystic 
teratoma 
25 14.0 
3.  Mucinous 
cystadenoma 
13 7.3 
4.  Thecoma-fibroma 02 1.1 
5.  Granulosa cell tumor 02 1.1 
6.  Brenner tumor 01 0.6  
ii. Malignant  - 26 (14.6%) 52+1.4 
1.  Serous 
cystadenocarcinoma 
12 6.7 
2.  Mucinous 
cystadenocarcinoma 
05 2.8 
3.  Endometroid 
carcinoma 
03 1.7  
4.  Immature teratoma 02 1.1 
5.  Clear cell carcinoma 01 0.6 
6.  Dysgerminoma 01 0.6 
7.  Undifferentiated 
sarcoma 
01 0.6 
C. Secondary / Metastatic Tumor 
1.  Krukenberg tumor 01 0.6 
Table 2:   Frequency of Ovarian Tumors according to 
Histogenesis (n=100) 
Sr.N
o. 
Primary Tumors No of cases 
(n) 
Percentage (%) 
I. Surface Epithelial Tumors (n = 45) 
A. Benign 
1.  Serous cystadenoma 31 31 
2.  Mucinous cystadenoma 13 13 
3.  Brenner tumor 01 01 
B. Malignant 
1.  Serous cyst adenocarcinoma 12 12 
2.  Mucinous cystadenocarcinoma 05 05 
3.  Endometroid carcinoma 03 03 
4.  Clear cell carcinoma 01 01 
II. Germ Cell Tumors (n=28) 
1.  Mature teratoma + dermoid cysts 25 25 
2.  Immature teratoma 02 02 
3.  Dysgerminoma 01 01 
III. Sex Cord –Stromal Tumors (n=04) 
1.  Granulosa cell tumor 02 02 
2.  Fibroma-thecoma 02 02 
IV. Undifferentiated sarcoma 01 01 
Secondary / Metastatic Carcinoma 
(Krukenberg tumour) 01 01 
 
 
Figure 1: Endometriotic Cyst; Cyst wall lined by tall 
columnar epithelial cells and hemosiderin laden 
macrophages  (H&E X 200) 
 
Figure 2: Mucinous Cystadenoma; Multiple cystic 
spaces lined by cells having apical mucin and basal 
nuclei 
(H&E X 200x) 
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Figure 3: Granulosa cell tumor; Sheets of granulosa 
cells having coffee bean nuclei (H&E X 400) 
 
Discussion 
Ovarian cancer is the second commonest gynecological 
malignancy.
5 
The Indian literature review had narrated that 
ovarian malignancies ranks on the seventh number 
regarding the cancer related mortalities.
6,7 
The findings and 
results of current study showed that the non-neoplastic 
lesions are the commonest ones (43.8%), followed by 
benign ovarian tumors (41.6%) and then malignant ones 
(14.6%). Endometriotic ovarian cysts were seen in 21.2% 
cases of non-neoplastic pathologies. The results of current 
study are in accordance with the findings of Busacca et al 
reporting endometriotic ovarian cysts is 17%, amongst all 
benign ovarian lesions.
8 
Maggiore et al in 2015, concluded 
that these benign ovarian endometriotic cysts do not affect 
the ovulation.
9
 Other published studies had shown that in 
60% of the cases left ovary is affected. The common reason 
for this is the anatomical variation between right and left 
hemipelvis along with the menstrual reflux theory.
10, 
Lower 
levels of anti-Mullerian hormone (AMH) levels and antral 
follicle count are seen in women with endometriomas as 
compared to those who donnot have ovarian cysts, thus 
becoming the reason for reduced ovarian reserve.
12 
Follicular cysts were seen in 12.3% of our cases; this 
finding is supported by the results of study conducted by 
Kreuzer GF et al who reported that the follicular cysts were 
the most common (55%) ones followed by corpus luteal 
cysts in 45% cases of all benign ovarian disorders.
13 
Mavromatidis et-al, reported that follicular cysts usually 
have a benign course, but due to their rapidly enlarging 
tendency, they can become symptomatic requiring the 
surgical interventions.
14 
In order to avoid the false 
diagnosis, the accurate cytological diagnosis is necessary so 
that proper treatment can be initiated timely.
15 
Corpus luteal 
hemorrhagic cysts were present in 10.3% of the cases of 
current study and these findings are comparable with 
another study who further added that their presence in 25-
31% of cases can result in fatal outcomes.
16
 The 
anticoagulation therapy is considered as one of the 
predisposing factor for such pathology.
17 
The results of 
current study are supported by the findings of a published 
report for the year 2001, which showed that the frequency 
of benign lesions is more i.e 41.67%, as compared to the 
malignant ones.
18 
This finding is different from the 
published results of Hartageet al in 2000. He described that 
prevalence of benign ovarian lesions was 14% in his 
study.
19
 The non-neoplastic lesions and benign neoplastic 
lesions are common in the mean age of 30+1.6 and 37+1.8 
years. While the malignant lesions were seen in the females 
with the mean of 52+1.2 years. These findings are 
consistent with the published report of Berek et al in 2007. 
He observed that the non-neoplastic and benign ovarian 
lesions are more common in the age group of less than 40 
yrs. While malignant ones are more common in the age 
range between 50-60 years.
3  
The current study showed that serous cystadenoma was 
present in 17.4% of the cases. This finding is consistent 
with the results of Cheng et al. He concluded that ovarian 
serous cystadenomas are the common ovarian disorders and 
they are the precursors of low-grade serous carcinomas, 
because they are the hyperplastic expansion from epithelial 
inclusions, having clonal/neoplastic transformation 
potential.
20 
In another study Della et al reported  that, 
ovarian serous cystadenomas are amongst the rare 
disorders.
21
 Benign cystic teratomas are present in 14% of 
the total cases. This is consistent with the findings of 
Kahraman et-al who reported that 10-20% of all ovarian 
tumors comprises of benign cystic teratomas.
22
 Serous cyst 
adenocarcinoma was detected in 6.7% of all malignant 
tumors. Jemal et al in their study found serous cyst 
adenocarcinomas in 3% of all malignant tumours.
23
 
Mucinous cystadenocarcinoma was present in 2.8% of 
cases. This is supported by the Harrison et al; he described 
that the incidence of primary mucinous adenocarcinoma is 
usually low.
24 
The prognosis and treatment modalities of 
primary and metastatic mucinous adenocarcinomas are 
different. So, the accurate diagnosis is necessary for proper 
treatment.
25
  
 
Conclusion 
Non neoplastic cysts were the most common ovarian lesions 
seen in 43.8% cases. This was followed by benign ovarian 
lesions – 41.6 ±% and malignant ones in 14.6% cases. 
Surface epithelial tumors are the commonest. 
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